J

Jasper Therapeutics

47 employees

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$100M

from 13 investors over 13 rounds

J

Jasper Therapeutics raised $100M on September 27, 2021

Investors: Qiming Venture Partners USA, Avego Healthcare Capital, Velan Capital, Kingdon Capital Management, Metalmark Capital, Woodline Partners LP and Apeiron Investment Group

J

Jasper Therapeutics raised $14M on January 25, 2020

Investors: Qiming Venture Partners USA, TSVC and Abingworth

J

Jasper Therapeutics raised $35M on December 7, 2019

Investors: Qiming Venture Partners USA, Surveyor Capital and Abingworth

FAQ